Detalhe da pesquisa
1.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
N Engl J Med
; 386(7): 629-639, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904798
2.
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.
Br J Haematol
; 204(1): 160-170, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881141
3.
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.
Blood
; 139(12): 1863-1877, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932792
4.
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
Int J Cancer
; 153(4): 723-731, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119033
5.
Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study.
Br J Haematol
; 202(4): 785-795, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37325886
6.
The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy.
Haematologica
; 108(9): 2454-2466, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861406
7.
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas.
Haematologica
; 108(11): 3044-3057, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259566
8.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 380(1): 45-56, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501490
9.
Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life.
Haematologica
; 107(11): 2698-2707, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484681
10.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(10): 1403-1415, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516954
11.
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma.
Haematologica
; 106(3): 718-729, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079690
12.
The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.
Br J Haematol
; 191(5): 738-747, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410260
13.
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Br J Haematol
; 188(5): 685-691, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612478
14.
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients.
Br J Haematol
; 189(4): 661-671, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32017050
15.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31868632
16.
Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
Blood
; 132(22): 2401-2405, 2018 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30257882
17.
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
Br J Haematol
; 184(4): 616-624, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30095158
18.
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.
Acta Oncol
; 58(5): 690-699, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696346
19.
The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.
Br J Haematol
; 183(2): 225-234, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30080252
20.
Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL.
Blood Cells Mol Dis
; 73: 25-32, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30217760